50 years ago, the Slade family founded an organisation based on patient care, quality, innovation and integrity. Today that organisation is one of Australia’s leading chemotherapy compounders, delivering 500,000 infusions annually.

Slade Health boasts a strong network of TGA-licensed manufacturing facilities across the eastern seaboard, in Brisbane, Sydney and Melbourne. These facilities provide public and private hospitals nationally with chemotherapy, sterile compounded products and analgesics. This includes the extensive Icon Group network and greater Slade businesses.

Slade Health has a rigorous series of checks throughout the production and dispatch process to ensure product sterility, appropriate storage and timely delivery. The patient is at the centre of everything Slade does; the result is exceptional cancer care.